Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about InMed Pharmaceuticals
Recent news which mentions InMed Pharmaceuticals
EXCLUSIVE: New Alzheimer's Treatment? Promising Cannabinoid Compound Shows Hope, InMed CEO Says
June 21, 2024
Tags
Eric A/ Adams
InMed Pharmaceuticals
Stories That Matter
From
Benzinga
Health Care, Biotech Leaders To Unveil Cutting-Edge Innovations
June 17, 2024
Tags
healthcare
Health Care
Virtual Event
From
Benzinga
InMed Pharmaceuticals Has Multiple Milestones Coming Up In 2024, With A Focus On Three Conditions With An Unmet Need
January 25, 2024
Tickers
INM
Tags
Market News
Benzinga
Penny Stocks
From
Benzinga
InMed's (NASDAQ: INM) Latest Research Demonstrates Potential In Treating Alzheimer's With A Rare Cannabinoid Analog
December 11, 2023
Tickers
INM
Tags
Partner Content
Biotech
INM
From
Benzinga
InMed Pharmaceuticals, A Cannabinoid-Focused Company, Sponsored Benzinga's Cannabis Capital Conference
October 16, 2023
Tickers
INM
Tags
INM
InMed Pharmaceuticals
Market News
From
Benzinga
This Clinical Stage BioPharma Is Seeing Solid Growth In Rare Cannabinoid Demand From The Health And Wellness Sector
September 15, 2023
Tickers
INM
Tags
Penny Stocks
Benzinga
Market News
From
Benzinga
Despite Global Economic Pressures, InMed Pharma's Accomplishments In 2022 Could Be A Catalyst For Further Growth In 2023
March 17, 2023
Tickers
INM
Tags
Market News
Benzinga
Penny Stocks
From
Benzinga
This Company's Rare Cannabinoids May Hold Promise In The Treatment Of Neurodegenerative Diseases Like Alzheimer's
January 11, 2023
Tickers
INM
Tags
INM
InMed Pharmaceuticals
Partner Content
From
Benzinga
InMed Pharmaceuticals: The Clinical-Stage Company Setting Sites On Dominating Rare Cannabinoid Production And Commercialization Across Global Markets
June 23, 2022
Tickers
INM
Tags
INM
Health Care
General
From
Benzinga
InMed Pharmaceuticals To Acquire BayMedica, Rare Cannabinoid Manufacturer, For ~$3.66M
September 13, 2021
Tickers
INM
Tags
General
InMed Pharmaceuticals
M&A
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.